APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin D2 Receptor 2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prostaglandin D2 Receptor 2 Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchProstaglandin D2 Receptor 2 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin D2 Receptor 2 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Prostaglandin D2 Receptor 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin D2 Receptor 2 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin D2 Receptor 2 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Prostaglandin D2 Receptor 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prostaglandin D2 Receptor 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prostaglandin D2 Receptor 2 market include Novartis AG, Merck & Co., Inc., Taisho Pharmaceutical Holdings Co., Ltd., Pulmagen Therapeutics LLP, Panmira Pharmaceuticals, LLC., Oxagen Limited, Ligand Pharmaceuticals, Inc., Brickell Biotech, Inc. and Allergan Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prostaglandin D2 Receptor 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostaglandin D2 Receptor 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostaglandin D2 Receptor 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostaglandin D2 Receptor 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostaglandin D2 Receptor 2 Segment by Company

Novartis AG

Merck & Co., Inc.

Taisho Pharmaceutical Holdings Co., Ltd.

Pulmagen Therapeutics LLP

Panmira Pharmaceuticals, LLC.

Oxagen Limited

Ligand Pharmaceuticals, Inc.

Brickell Biotech, Inc.

Allergan Plc

Prostaglandin D2 Receptor 2 Segment by Type

ADC-7405

BBI-5000

MK-1029

OC-2417

Others

Prostaglandin D2 Receptor 2 Segment by Application

Atopic Dermatitis

Chronic Obstructive Pulmonary Disease

Allergic Asthma

Others

Prostaglandin D2 Receptor 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prostaglandin D2 Receptor 2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prostaglandin D2 Receptor 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prostaglandin D2 Receptor 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Prostaglandin D2 Receptor 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin D2 Receptor 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin D2 Receptor 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin D2 Receptor 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostaglandin D2 Receptor 2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostaglandin D2 Receptor 2 industry.

Chapter 3: Detailed analysis of Prostaglandin D2 Receptor 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prostaglandin D2 Receptor 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prostaglandin D2 Receptor 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prostaglandin D2 Receptor 2 Industry Trends Table 2. Prostaglandin D2 Receptor 2 Industry Drivers Table 3. Prostaglandin D2 Receptor 2 Industry Opportunities and Challenges Table 4. Prostaglandin D2 Receptor 2 Industry Restraints Table 5. Global Prostaglandin D2 Receptor 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prostaglandin D2 Receptor 2 Revenue Share by Company (2021-2026) Table 7. Global Prostaglandin D2 Receptor 2 Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Prostaglandin D2 Receptor 2 Sales Volume Share by Company (2021-2026) Table 9. Global Prostaglandin D2 Receptor 2 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Prostaglandin D2 Receptor 2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prostaglandin D2 Receptor 2 Key Company Manufacturing Base & Headquarters Table 12. Global Prostaglandin D2 Receptor 2 Company, Product Type & Application Table 13. Global Prostaglandin D2 Receptor 2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostaglandin D2 Receptor 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ADC-7405 Table 18. Significant Companies of BBI-5000 Table 19. Significant Companies of MK-1029 Table 20. Significant Companies of OC-2417 Table 21. Significant Companies of Others Table 22. Global Prostaglandin D2 Receptor 2 Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Prostaglandin D2 Receptor 2 Sales Volume by Type (2021-2026) & (W Units) Table 24. Global Prostaglandin D2 Receptor 2 Sales Volume by Type (2027-2032) & (W Units) Table 25. Global Prostaglandin D2 Receptor 2 Sales Volume Share by Type (2021-2026) Table 26. Global Prostaglandin D2 Receptor 2 Sales Volume Share by Type (2027-2032) Table 27. Global Prostaglandin D2 Receptor 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Prostaglandin D2 Receptor 2 Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Prostaglandin D2 Receptor 2 Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Prostaglandin D2 Receptor 2 Sales Value Share by Type (2021-2026) Table 31. Global Prostaglandin D2 Receptor 2 Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Atopic Dermatitis Table 33. Significant Companies of Chronic Obstructive Pulmonary Disease Table 34. Significant Companies of Allergic Asthma Table 35. Significant Companies of Others Table 36. Global Prostaglandin D2 Receptor 2 Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Prostaglandin D2 Receptor 2 Sales Volume by Application (2021-2026) & (W Units) Table 38. Global Prostaglandin D2 Receptor 2 Sales Volume by Application (2027-2032) & (W Units) Table 39. Global Prostaglandin D2 Receptor 2 Sales Volume Share by Application (2021-2026) Table 40. Global Prostaglandin D2 Receptor 2 Sales Volume Share by Application (2027-2032) Table 41. Global Prostaglandin D2 Receptor 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Prostaglandin D2 Receptor 2 Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Prostaglandin D2 Receptor 2 Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Prostaglandin D2 Receptor 2 Sales Value Share by Application (2021-2026) Table 45. Global Prostaglandin D2 Receptor 2 Sales Value Share by Application (2027-2032) Table 46. Global Prostaglandin D2 Receptor 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Prostaglandin D2 Receptor 2 Sales by Region (2021-2026) & (W Units) Table 48. Global Prostaglandin D2 Receptor 2 Sales Market Share by Region (2021-2026) Table 49. Global Prostaglandin D2 Receptor 2 Sales by Region (2027-2032) & (W Units) Table 50. Global Prostaglandin D2 Receptor 2 Sales Market Share by Region (2027-2032) Table 51. Global Prostaglandin D2 Receptor 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Prostaglandin D2 Receptor 2 Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Prostaglandin D2 Receptor 2 Sales Value Share by Region (2021-2026) Table 54. Global Prostaglandin D2 Receptor 2 Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Prostaglandin D2 Receptor 2 Sales Value Share by Region (2027-2032) Table 56. Global Prostaglandin D2 Receptor 2 Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Prostaglandin D2 Receptor 2 Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Prostaglandin D2 Receptor 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. Global Prostaglandin D2 Receptor 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 61. Global Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2026) Table 62. Global Prostaglandin D2 Receptor 2 Sales by Country (2027-2032) & (W Units) Table 63. Global Prostaglandin D2 Receptor 2 Sales Market Share by Country (2027-2032) Table 64. Global Prostaglandin D2 Receptor 2 Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Prostaglandin D2 Receptor 2 Sales Value Market Share by Country (2021-2026) Table 66. Global Prostaglandin D2 Receptor 2 Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Prostaglandin D2 Receptor 2 Sales Value Market Share by Country (2027-2032) Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis AG Prostaglandin D2 Receptor 2 Product Portfolio Table 72. Novartis AG Recent Development Table 73. Merck & Co., Inc. Company Information Table 74. Merck & Co., Inc. Business Overview Table 75. Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck & Co., Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 77. Merck & Co., Inc. Recent Development Table 78. Taisho Pharmaceutical Holdings Co., Ltd. Company Information Table 79. Taisho Pharmaceutical Holdings Co., Ltd. Business Overview Table 80. Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Product Portfolio Table 82. Taisho Pharmaceutical Holdings Co., Ltd. Recent Development Table 83. Pulmagen Therapeutics LLP Company Information Table 84. Pulmagen Therapeutics LLP Business Overview Table 85. Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Product Portfolio Table 87. Pulmagen Therapeutics LLP Recent Development Table 88. Panmira Pharmaceuticals, LLC. Company Information Table 89. Panmira Pharmaceuticals, LLC. Business Overview Table 90. Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Product Portfolio Table 92. Panmira Pharmaceuticals, LLC. Recent Development Table 93. Oxagen Limited Company Information Table 94. Oxagen Limited Business Overview Table 95. Oxagen Limited Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Oxagen Limited Prostaglandin D2 Receptor 2 Product Portfolio Table 97. Oxagen Limited Recent Development Table 98. Ligand Pharmaceuticals, Inc. Company Information Table 99. Ligand Pharmaceuticals, Inc. Business Overview Table 100. Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 102. Ligand Pharmaceuticals, Inc. Recent Development Table 103. Brickell Biotech, Inc. Company Information Table 104. Brickell Biotech, Inc. Business Overview Table 105. Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 107. Brickell Biotech, Inc. Recent Development Table 108. Allergan Plc Company Information Table 109. Allergan Plc Business Overview Table 110. Allergan Plc Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Allergan Plc Prostaglandin D2 Receptor 2 Product Portfolio Table 112. Allergan Plc Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Prostaglandin D2 Receptor 2 Distributors List Table 116. Prostaglandin D2 Receptor 2 Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Prostaglandin D2 Receptor 2 Product Image Figure 2. Global Prostaglandin D2 Receptor 2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin D2 Receptor 2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prostaglandin D2 Receptor 2 Sales (2021-2032) & (W Units) Figure 5. Global Prostaglandin D2 Receptor 2 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Prostaglandin D2 Receptor 2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ADC-7405 Image Figure 10. BBI-5000 Image Figure 11. MK-1029 Image Figure 12. OC-2417 Image Figure 13. Others Image Figure 14. Global Prostaglandin D2 Receptor 2 Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Prostaglandin D2 Receptor 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Prostaglandin D2 Receptor 2 Sales Volume Share by Type (2021-2032) Figure 17. Global Prostaglandin D2 Receptor 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Prostaglandin D2 Receptor 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Prostaglandin D2 Receptor 2 Sales Value Share by Type (2021-2032) Figure 20. Atopic Dermatitis Image Figure 21. Chronic Obstructive Pulmonary Disease Image Figure 22. Allergic Asthma Image Figure 23. Others Image Figure 24. Global Prostaglandin D2 Receptor 2 Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Prostaglandin D2 Receptor 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Prostaglandin D2 Receptor 2 Sales Volume Share by Application (2021-2032) Figure 27. Global Prostaglandin D2 Receptor 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Prostaglandin D2 Receptor 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Prostaglandin D2 Receptor 2 Sales Value Share by Application (2021-2032) Figure 30. Global Prostaglandin D2 Receptor 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 31. Global Prostaglandin D2 Receptor 2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Prostaglandin D2 Receptor 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Prostaglandin D2 Receptor 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Prostaglandin D2 Receptor 2 Sales Value (2021-2032) & (US$ Million) Figure 35. North America Prostaglandin D2 Receptor 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Prostaglandin D2 Receptor 2 Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Prostaglandin D2 Receptor 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Prostaglandin D2 Receptor 2 Sales Value (2021-2032) & (US$ Million) Figure 41. South America Prostaglandin D2 Receptor 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Prostaglandin D2 Receptor 2 Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Prostaglandin D2 Receptor 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Prostaglandin D2 Receptor 2 Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Prostaglandin D2 Receptor 2 Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • ADC-7405
  • BBI-5000
  • MK-1029
  • OC-2417
  • Others
Applications
  • Atopic Dermatitis
  • Chronic Obstructive Pulmonary Disease
  • Allergic Asthma
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Pulmagen Therapeutics LLP
  • Panmira Pharmaceuticals, LLC.
  • Oxagen Limited
  • Ligand Pharmaceuticals, Inc.
  • Brickell Biotech, Inc.
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostaglandin D2 Receptor 2 Sales Value (2021-2032)
  4. 1.2.2 Global Prostaglandin D2 Receptor 2 Sales Volume (2021-2032)
  5. 1.2.3 Global Prostaglandin D2 Receptor 2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prostaglandin D2 Receptor 2 Market Dynamics
  1. 2.1 Prostaglandin D2 Receptor 2 Industry Trends
  2. 2.2 Prostaglandin D2 Receptor 2 Industry Drivers
  3. 2.3 Prostaglandin D2 Receptor 2 Industry Opportunities and Challenges
  4. 2.4 Prostaglandin D2 Receptor 2 Industry Restraints
3 Prostaglandin D2 Receptor 2 Market by Company
  1. 3.1 Global Prostaglandin D2 Receptor 2 Company Revenue Ranking in 2025
  2. 3.2 Global Prostaglandin D2 Receptor 2 Revenue by Company (2021-2026)
  3. 3.3 Global Prostaglandin D2 Receptor 2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Prostaglandin D2 Receptor 2 Average Price by Company (2021-2026)
  5. 3.5 Global Prostaglandin D2 Receptor 2 Company Ranking (2024-2026)
  6. 3.6 Global Prostaglandin D2 Receptor 2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Prostaglandin D2 Receptor 2 Company Product Type and Application
  8. 3.8 Global Prostaglandin D2 Receptor 2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prostaglandin D2 Receptor 2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prostaglandin D2 Receptor 2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prostaglandin D2 Receptor 2 Market by Type
  1. 4.1 Prostaglandin D2 Receptor 2 Type Introduction
  2. 4.1.1 ADC-7405
  3. 4.1.2 BBI-5000
  4. 4.1.3 MK-1029
  5. 4.1.4 OC-2417
  6. 4.1.5 Others
  7. 4.2 Global Prostaglandin D2 Receptor 2 Sales Volume by Type
  8. 4.2.1 Global Prostaglandin D2 Receptor 2 Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Prostaglandin D2 Receptor 2 Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Prostaglandin D2 Receptor 2 Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Prostaglandin D2 Receptor 2 Sales Value by Type
  12. 4.3.1 Global Prostaglandin D2 Receptor 2 Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Prostaglandin D2 Receptor 2 Sales Value by Type (2021-2032)
  14. 4.3.3 Global Prostaglandin D2 Receptor 2 Sales Value Share by Type (2021-2032)
5 Prostaglandin D2 Receptor 2 Market by Application
  1. 5.1 Prostaglandin D2 Receptor 2 Application Introduction
  2. 5.1.1 Atopic Dermatitis
  3. 5.1.2 Chronic Obstructive Pulmonary Disease
  4. 5.1.3 Allergic Asthma
  5. 5.1.4 Others
  6. 5.2 Global Prostaglandin D2 Receptor 2 Sales Volume by Application
  7. 5.2.1 Global Prostaglandin D2 Receptor 2 Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Prostaglandin D2 Receptor 2 Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Prostaglandin D2 Receptor 2 Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Prostaglandin D2 Receptor 2 Sales Value by Application
  11. 5.3.1 Global Prostaglandin D2 Receptor 2 Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Prostaglandin D2 Receptor 2 Sales Value by Application (2021-2032)
  13. 5.3.3 Global Prostaglandin D2 Receptor 2 Sales Value Share by Application (2021-2032)
6 Prostaglandin D2 Receptor 2 Regional Sales and Value Analysis
  1. 6.1 Global Prostaglandin D2 Receptor 2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostaglandin D2 Receptor 2 Sales by Region (2021-2032)
  3. 6.2.1 Global Prostaglandin D2 Receptor 2 Sales by Region: 2021-2026
  4. 6.2.2 Global Prostaglandin D2 Receptor 2 Sales by Region (2027-2032)
  5. 6.3 Global Prostaglandin D2 Receptor 2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prostaglandin D2 Receptor 2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prostaglandin D2 Receptor 2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prostaglandin D2 Receptor 2 Sales Value by Region (2027-2032)
  9. 6.5 Global Prostaglandin D2 Receptor 2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prostaglandin D2 Receptor 2 Sales Value (2021-2032)
  12. 6.6.2 North America Prostaglandin D2 Receptor 2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prostaglandin D2 Receptor 2 Sales Value (2021-2032)
  15. 6.7.2 Europe Prostaglandin D2 Receptor 2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prostaglandin D2 Receptor 2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prostaglandin D2 Receptor 2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prostaglandin D2 Receptor 2 Sales Value (2021-2032)
  21. 6.9.2 South America Prostaglandin D2 Receptor 2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prostaglandin D2 Receptor 2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prostaglandin D2 Receptor 2 Sales Value Share by Country, 2025 VS 2032
7 Prostaglandin D2 Receptor 2 Country-level Sales and Value Analysis
  1. 7.1 Global Prostaglandin D2 Receptor 2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prostaglandin D2 Receptor 2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
  4. 7.3.1 Global Prostaglandin D2 Receptor 2 Sales by Country (2021-2026)
  5. 7.3.2 Global Prostaglandin D2 Receptor 2 Sales by Country (2027-2032)
  6. 7.4 Global Prostaglandin D2 Receptor 2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prostaglandin D2 Receptor 2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prostaglandin D2 Receptor 2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prostaglandin D2 Receptor 2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prostaglandin D2 Receptor 2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prostaglandin D2 Receptor 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Prostaglandin D2 Receptor 2 Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Taisho Pharmaceutical Holdings Co., Ltd.
  14. 8.3.1 Taisho Pharmaceutical Holdings Co., Ltd. Company Information
  15. 8.3.2 Taisho Pharmaceutical Holdings Co., Ltd. Business Overview
  16. 8.3.3 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Product Portfolio
  18. 8.3.5 Taisho Pharmaceutical Holdings Co., Ltd. Recent Developments
  19. 8.4 Pulmagen Therapeutics LLP
  20. 8.4.1 Pulmagen Therapeutics LLP Company Information
  21. 8.4.2 Pulmagen Therapeutics LLP Business Overview
  22. 8.4.3 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Product Portfolio
  24. 8.4.5 Pulmagen Therapeutics LLP Recent Developments
  25. 8.5 Panmira Pharmaceuticals, LLC.
  26. 8.5.1 Panmira Pharmaceuticals, LLC. Company Information
  27. 8.5.2 Panmira Pharmaceuticals, LLC. Business Overview
  28. 8.5.3 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Product Portfolio
  30. 8.5.5 Panmira Pharmaceuticals, LLC. Recent Developments
  31. 8.6 Oxagen Limited
  32. 8.6.1 Oxagen Limited Company Information
  33. 8.6.2 Oxagen Limited Business Overview
  34. 8.6.3 Oxagen Limited Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Oxagen Limited Prostaglandin D2 Receptor 2 Product Portfolio
  36. 8.6.5 Oxagen Limited Recent Developments
  37. 8.7 Ligand Pharmaceuticals, Inc.
  38. 8.7.1 Ligand Pharmaceuticals, Inc. Company Information
  39. 8.7.2 Ligand Pharmaceuticals, Inc. Business Overview
  40. 8.7.3 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  42. 8.7.5 Ligand Pharmaceuticals, Inc. Recent Developments
  43. 8.8 Brickell Biotech, Inc.
  44. 8.8.1 Brickell Biotech, Inc. Company Information
  45. 8.8.2 Brickell Biotech, Inc. Business Overview
  46. 8.8.3 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  48. 8.8.5 Brickell Biotech, Inc. Recent Developments
  49. 8.9 Allergan Plc
  50. 8.9.1 Allergan Plc Company Information
  51. 8.9.2 Allergan Plc Business Overview
  52. 8.9.3 Allergan Plc Prostaglandin D2 Receptor 2 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Allergan Plc Prostaglandin D2 Receptor 2 Product Portfolio
  54. 8.9.5 Allergan Plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostaglandin D2 Receptor 2 Value Chain Analysis
  2. 9.1.1 Prostaglandin D2 Receptor 2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostaglandin D2 Receptor 2 Sales Mode & Process
  6. 9.2 Prostaglandin D2 Receptor 2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostaglandin D2 Receptor 2 Distributors
  9. 9.2.3 Prostaglandin D2 Receptor 2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst